AI supercharges diabetes care: new digital tool aims to lower blood sugar
NCT ID NCT05884775
First seen Mar 03, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This study tests a smartphone-based tool called iMatter2 that uses artificial intelligence to help people with type 2 diabetes track their symptoms and communicate with their doctors. About 353 adults with uncontrolled diabetes will use the tool or receive usual care for 12 months. The main goal is to see if the tool helps lower blood sugar levels (HbA1c).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.